Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Myocarditis I: Introduction

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013

Same author

Emotional stressors trigger cardiovascular events.

International journal of clinical practice·2012

Same author

Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011

Same author

The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.

International journal of impotence research·2009

Same author

How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.

International journal of impotence research·2009

Same author

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors.

International journal of impotence research·2009

Search research articles

Related Experiment Video

Updated: Jul 22, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Myocardial regeneration: present and future trends.

S Etzion¹, L H Kedes, R A Kloner

¹Neufeld Cardiac Research Institute, Tel-Aviv University, Sheba Medical Center, Tel-Hashomer, Israel.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions

|January 20, 2004

Summary

Regenerating heart muscle after injury is challenging as cardiomyocytes do not proliferate. Promising strategies like gene therapy and cell transplantation show potential for myocardial regeneration in animal models, offering hope for heart attack treatment.

More Related Videos

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Related Experiment Videos

Last Updated: Jul 22, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Area of Science:

Cardiovascular Research
Regenerative Medicine
Biotechnology

Background:

Cardiomyocytes are terminally differentiated cells that cannot proliferate after myocardial injury.
Heart failure resulting from myocardial damage necessitates innovative therapeutic strategies.
Current treatments for heart failure, such as transplantation, face limitations, especially for elderly patients.

Purpose of the Study:

To explore the potential of genetic modulation, cell transplantation, and tissue engineering for myocardial regeneration.
To evaluate the efficacy of these approaches in animal models for treating heart failure.
To identify challenges hindering the clinical translation of these regenerative strategies.

Main Methods:

Investigating genetic modulation techniques to enhance cardiomyocyte function or proliferation.
Assessing the integration and therapeutic effects of transplanted myogenic cells in injured myocardium.
Exploring tissue engineering approaches for creating functional cardiac tissue grafts.

Main Results:

Animal models demonstrate the feasibility of using genetic materials or myogenic cells for myocardial repair.
These regenerative strategies show promise as alternatives to heart transplantation, particularly for specific patient groups.
Significant challenges remain in translating these experimental findings into efficient clinical therapies.

Conclusions:

Genetic modulation, cell transplantation, and tissue engineering represent promising avenues for myocardial regeneration.
While successful in preclinical studies, these approaches require further development to overcome existing hurdles.
Efficient therapeutic strategies for heart regeneration are still under development and not yet ready for widespread clinical application.